BSX vs MO · P/E 20, rev $16.75B vs P/E 14, rev $23.28B
Boston Scientific Corp (BSX) versus Altria Group (MO) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Altria Group (MO) is a tobacco company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported MO revenue for 2025-12-31 was $23.28B. Net income was $6.95B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. MO currently screens at market cap $115.14B and trailing P/E 14.4.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. MO currently screens at market cap $115.14B and trailing P/E 14.4.
Not investment advice. Open the BSX and MO stock pages for the full models.
Not investment advice.